Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Prostate Cancer: Diagnosis

Description: In the U.S., prostate cancer is the most commonly diagnosed and the second most common cause of cancer death in men. The incidence of prostate cancer is increasing at an average rate of 3% a year. This course discusses the symptoms and staging of prostate cancer and the methods used for diagnosis.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

DIAGNOSIS
4. Objectives
5. Symptoms
6. Diagnostic Methods
7. Staging
8. Screening
9. Progress Check

CASE STUDIES
10. Early Stage (Localized)
11. Locally Advanced Disease
12. Advanced Disease
13. Hormone-Refractory Disease

CONCLUSION
14. Summary


COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe the symptoms of locally advanced and metastatic prostate cancer
  • Explain the physical and imaging exams used to detect prostate cancer
  • Discuss the use of the TNM staging and Gleason grading systems for classification of the severity of prostate cancer
  • Explain how and why screening programs are used
  • Explore diagnostic options given a particular case history
  • Review the early signs and symptoms of prostate cancer
  • Review the genetic factors that influence the risk of developing prostate cancer
  • Recall the symptoms of locally advanced prostate cancer
  • Explore the appropriate diagnostic techniques for advanced prostate cancer
  • Review the importance of DRE in making a diagnosis
  • Recall the implication of circulating PSA levels
  • List common near-terminal events accompanying prostate cancer

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy